Cargando…

Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Tumor control and survival have improved with the use of radiotherapy (RT) plus concomitant and adjuvant chemotherapy, but the prognosis remain poor. In most cases the recurrence occurs within 7–9 months after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciammella, Patrizia, Podgornii, Ala, Galeandro, Maria, D’Abbiero, Nunziata, Pisanello, Anna, Botti, Andrea, Cagni, Elisabetta, Iori, Mauro, Iotti, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852333/ https://www.ncbi.nlm.nih.gov/pubmed/24066926 http://dx.doi.org/10.1186/1748-717X-8-222

Ejemplares similares

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

Efficacy of the Radiotherapy on Darier's Disease: An Indirect Evidence
por: Podgornii, Ala, et al.
Publicado: (2013)

The Use of Cardiac Stereotactic Radiation Therapy (SBRT) to Manage Ventricular Tachycardia: A Case Report, Review of the Literature and Technical Notes
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Extraskeletal multiple myeloma presenting with an atrial mass: a case report and a review of the literature
por: Vigo, Federica, et al.
Publicado: (2012)

Variations in Head and Neck Treatment Plan Quality Assessment Among Radiation Oncologists and Medical Physicists in a Single Radiotherapy Department
por: Cagni, Elisabetta, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
por: Najafi, Masoumeh, et al.
Publicado: (2023)

Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL)
por: Ciammella, Patrizia, et al.
Publicado: (2022)

Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes
por: Cozzi, Salvatore, et al.
Publicado: (2023)

Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?
por: Simoni, Nicola, et al.
Publicado: (2022)

Radiation-induced breast angiosarcoma: report of two patients after accelerated partial breast irradiation (APBI) and review of the literature
por: Cozzi, Salvatore, et al.
Publicado: (2021)

Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Lattice Radiation Therapy in clinical practice: A systematic review
por: Iori, Federico, et al.
Publicado: (2022)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution
por: Blamek, Sławomir, et al.
Publicado: (2012)

Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Extracranial metastases in secondary glioblastoma multiforme: a case report
por: Rossi, Jessica, et al.
Publicado: (2020)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
por: Arpa, Donatella, et al.
Publicado: (2021)

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report
por: Guan, Yun, et al.
Publicado: (2022)

Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
por: Jablonska, Paola Anna, et al.
Publicado: (2019)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Radiotherapy Planning and Molecular Imaging in Lung Cancer
por: Filice, Angelina, et al.
Publicado: (2020)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results
por: Pouessel, Damien, et al.
Publicado: (2023)

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
por: Jablonska, Paola Anna, et al.
Publicado: (2019)

Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge
por: Navarria, Pierina, et al.
Publicado: (2016)

Adjuvant treatment of meningioma with stereotactic radiation surgery and hypofractionated stereotactic radiation surgery: Patterns of care and survival in a large, hospital database
por: Albert, Ashley, et al.
Publicado: (2018)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Intracranial chordoma: radiosurgery, hypofractionated stereotactic radiotherapy and treatment outcomes
por: Napieralska, Aleksandra, et al.
Publicado: (2021)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation
por: Iori, Federico, et al.
Publicado: (2022)

State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis
por: Najafi, Masoumeh, et al.
Publicado: (2022)

The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes
por: Cozzi, Salvatore, et al.
Publicado: (2022)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d5mh6273dqfc1earibm3g69sj9